Psychology & Psychiatry

Study finds men most attractive with heavy-stubble

(Medical Xpress)—A research team from the Evolution and Ecology Research Centre at the University of New South Wales has found that women find men most attractive when they have approximately ten days of beard growth. In ...

HIV & AIDS

Stopping HIV in its tracks

Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread ...

Psychology & Psychiatry

Reproductive hormones related to how attractive a woman smells

Reproductive hormones control a woman's monthly cycle and regulate fertility. Reproductive hormones are also related to how attractive a woman smells a study now shows. Researchers at the University of Bern demonstrate that ...

Obstetrics & gynaecology

EU suspends sale of contraceptive implant

The sale of a contraceptive implant has been suspended for three months across the European Union after an Irish regulator said it was temporarily withholding renewal of the device's commercial licence.

Health

Most U.S. teens aren't 'doing it'

(HealthDay)—Sex is everywhere in the media, and so you may be convinced that today's teens are always looking to "hook-up." But new federal research says it's just not so.

Obstetrics & gynaecology

Put birth control in place right after childbirth

(HealthDay)—Obstetrician-gynecologists should counsel pregnant women about use of long-acting reversible contraception, such as implants and IUDs, immediately after they give birth, a leading group of U.S. doctors says.

Medications

Six surprising drug interactions you should know about

As the UK population grows older, more and more people are using a combination of drugs to treat multiple conditions. This can lead to interactions and side effects that we all need to be aware of.

Diabetes

Low thromboembolism risk for contraceptive use in diabetes

(HealthDay)—For women with diabetes who are using hormonal contraception, the absolute risk of thromboembolism is low, with the lowest rates seen with use of intrauterine and subdermal contraceptives, according to a study ...

page 1 from 23